close
Solutions
keyboard_arrow_downServices
keyboard_arrow_downSupport & Resources
keyboard_arrow_downCompany
keyboard_arrow_downContact
Randox Health search
The RIQAS Human Urine EQA programme is designed to monitor the performance of 25 routine chemistry assays in urine.
Lyophilised material for enhanced stability
Submit results and view reports online via RIQAS.Net
World's largest EQA scheme ensuring peer groups are maximised
Flexible options available with bi-weekly or monthly reporting - icon attached Rapid Report TAT
Cycle Starts:
RQ9115 (Bi-Weekly) – January 2026
RQ9185 (Monthly) – July 2026
Accredited to ISO/IEC 17043:2023
Get in touch to discover more
To find out more about RIQAS EQA or to get in touch with your local Randox Representative, enquire now.
| Description | Frequency | Size | Cat No | |
|---|---|---|---|---|
| Human Urine | Bi-Weekly | 24 x 10 ml | RQ9115 | |
| Human Urine | Monthly | 12 x 10 ml | RQ9185 |
Parameters
- ACR
- Dopamine
- Phosphate (Inorganic)
- Albumin/Microalbumin
- Epinephrine
- Potassium
- Amylase
- Glucose
- Protein (Total)
- Anion Gap*
- Metanephrine
- Protein/Creatinine Ratio*
- Calcium
- Norepinephrine
- Sodium
- Chloride
- Normetanephrine
- Urea
- Copper
- Magnesium
- Uric Acid
- Cortisol
- Osmolality
- VMA
- Creatinine
- Oxalate
- 5-HIAA
*Pilot Study Ongoing
Please note, product availability may vary country to country.
Related RIQAS EQA Programmes
Urinalysis
Therapeutic Drugs
Urine Toxicology
